Much of the group's research has been related to AML patients. Important prognostic biomarkers have been identified through laboratory experiments and animal testing, and this work has been continued in clinical studies. The group is also involved in other cell therapy-related projects, including in cooperation with the Prostate Cancer Therapy Research Group. Access to stem cell research facilities will bring new possibilities for both in vitro and clinical studies. There is also a leukaemia research group in haematology headed by Øystein Bruserud. This group will also be taking part in the project, but concrete plans have yet to be finalised. The Department of Immunology and Transfusion Medicine has engaged in a considerable amount of stem cell research in cooperation with researchers in the Western Norway health region. It has previously focused on the cryopreservation of cells. Under Tor Hervig's leadership, the plan is now to resume work on a large-scale project on platelets, stem cells and growth factors – a field that is also related to the work carried out by the Tissue Engineering Group.